Recurring Limited Submissions

NSF-23-558: Accelerating Research Translation (ART)

Slots: 1

Deadlines

Internal Deadline: Contact RII.

LOI: Not required.

External Deadline: May 9, 2023

Recurring Deadlines: September 18, 2024; Third Wednesday in September, Annually Thereafter

Award Information

Award Type: Cooperative Agreement

Estimated Number of Awards: 10

Anticipated Award Amount: $60,000,000

Who May Serve as PI: No restrictions or limits.

Link to Award: https://www.nsf.gov/pubs/2023/nsf23558/nsf23558.htm

Process for Limited Submissions

PIs must submit their application as a Limited Submission through the Research Initiatives and Infrastructure (RII) Application Portal: https://rii.usc.edu/oor-portal/. Use the template provided here:

RII-Limited-Submission-Application-Template.

Materials to submit include:

(1) Two-Page Proposal Summary (0.5” margins; single-spaced; font type: Arial, Helvetica, or Georgia typeface; font size: 11 pt). Page limit includes references and illustrations. Pages that exceed the 2-page limit will be excluded from review. You must use the template linked above.
(2) CV – (5 pages maximum)

Note: The portal requires information about the PIs in addition to department and contact information, including the 10-digit USC ID#, Gender, and Ethnicity. Please have this material prepared before beginning this application.

Purpose

The National Science Foundation (NSF) seeks to increase the scale and pace of advancing discoveries made while conducting academic research into tangible solutions that benefit the public. This is the primary aim of the “Accelerating Research Translation” (ART) program. Specifically, the primary goals of this program are to build capacity and infrastructure for translational research at U.S. Institutions of Higher Education (IHEs) and to enhance their role in regional innovation ecosystems. In addition, this program seeks to effectively train graduate students and postdoctoral researchers in translational research, benefiting them across a range of career options.

A particular intent of ART is to support IHEs that want to build the necessary infrastructure to boost the overall institutional capacity to accelerate the pace and scale of translation of fundamental research outcomes into practice by supporting the development of a range of activities essential for this activity. The ART program is not intended to support IHEs that already have high levels of translational research activity as part of their R&D enterprise (as noted by their number of invention disclosures, patents issued, start-ups, licenses/options, revenue from royalties, the overall volume of industry-funded research, broad adoption of research outputs by communities or constituents, etc.). Such institutions are encouraged to become part of the ART network as valuable collaborators, providing expertise in building the necessary infrastructure for translational research at other IHEs responding to this solicitation. The ART program is also not intended as a resource for conducting additional fundamental research. See sections II and VI of this solicitation for additional information.

This solicitation seeks proposals that enable IHE-based teams to propose a blend of: (1) activities that will help build and/or strengthen the institutional infrastructure to sustainably grow the institutional capacity for research translation in the short and long terms; (2) educational/training opportunities, especially for graduate students and postdoctoral researchers, to become entrepreneurs and/or seek use-inspired and/or translational research-oriented careers in the public and/or private sectors; and (3) specific, translational research activities that offer immediate opportunities for transition to practice to create economic and/or societal impact. The funded teams will form a nationwide network of ‘ART Ambassadors’ who will champion the cause of translational research.

Visit our Institutionally Limited Submission webpage for more updates and other announcements.

The Pew Charitable Trusts: 2024 Pew Biomedical Scholars

Slots: 1

Deadlines

Internal Deadline: Friday, April 7, 2023

LOI: May 17, 2023 – nomination form

External Deadline: September 7, 2023

Award Information

Type: Grant

Estimated Number of Awards: Approximately 20-24

Anticipated Amount: $300,000; $75,000 per year for a four-year period

Link to Award: https://www.pewtrusts.org/en/projects/pew-biomedical-scholars/program-details

Who May Serve as PI:

Candidates must meet all of the following eligibility requirements:

Hold a doctorate in biomedical sciences, medicine, or a related field, including engineering or the physical sciences.
As of Sept. 7, 2023, run an independent lab and hold a full-time appointment at the rank of assistant professor. (Appointments such as research assistant professor, adjunct assistant professor, assistant professor research track, visiting professor, or instructor are not eligible).
Must not have been appointed as an assistant professor at any institution prior to June 12, 2019, whether or not such an appointment was on a tenure track. Time spent in clinical internships, residencies, in work toward board certification, or on parental leave does not count as part of this four-year limit. Candidates who need an exception on the four-year limit should contact Pew’s program office to ensure that application reviewers are aware an exception has been given.
- Please note that the eligibility criteria above have been temporarily expanded to account for COVID-related lab shutdowns. Please direct any questions to the program office at scholarsapp@pewtrusts.org.
May apply to the program a maximum of two times. All applicants must be nominated by their institution and must complete the 2024 online application.
If applicants have appointments at more than one eligible nominating institution or affiliate, they may not reapply in a subsequent year from a different nominating entity.
May not be nominated for the Pew Scholars Program and the Pew-Stewart Scholars Program for Cancer Research in the same year.

Based on their performance during their education and training, candidates should demonstrate outstanding promise as contributors in science relevant to human health. This program does not fund clinical trials research. Strong proposals will incorporate particularly creative and pioneering approaches to basic, translational, and applied biomedical research. Candidates whose work is based on biomedical principles but who bring in concepts and theories from more diverse fields are encouraged to apply.

Ideas with the potential to produce an unusually high impact are encouraged. Selection of the successful candidates will be based on a detailed description of the work that the applicant proposes to undertake, evaluations of the candidate’s performance, and notable past accomplishments, including honors, awards, and publications. In evaluating the candidates, the National Advisory Committee gives considerable weight to both the project proposal and the researcher, including evidence that the candidate is a successful independent investigator and has the skill set needed to carry out their high-impact proposal.

Funding from the NIH, other government sources, and project grants from nonprofit associations do not pose a conflict with the Pew scholars program. If you have questions concerning eligibility, please contact Kara Coleman, project director, Pew Biomedical Programs at 215-575-4925 in advance of applying.

Investigator effort

It is expected that Pew scholars will spend at least 80 percent of their time in work or activities related to the accomplishment of their overall research goals (which are not restricted to the specific aims proposed for this award). However, Pew provides flexible support to the general research aims of the scholar and does not require effort reporting.

Process for Limited Submissions

RII-Limited-Submission-Application-Template.

Materials to submit include:

(1) Two-Page Proposal Summary (0.5” margins; single-spaced; font type: Arial, Helvetica, or Georgia typeface; font size: 11 pt). Page limit includes references and illustrations. Pages that exceed the 2-page limit will be excluded from review. You must use the template linked above.
(2) CV – (5 pages maximum)

Purpose

The Pew Scholars Program in the Biomedical Sciences provides funding to young investigators of outstanding promise in science relevant to the advancement of human health. The program makes grants to selected academic institutions to support the independent research of outstanding individuals who are in their first few years of their appointment at the assistant professor level.

Budgetary Requirements:

An award of $75,000 per year for four years will be provided to the sponsoring institution for use by the scholar, subject to annual review of the scholar’s progress. Grant agreements will be issued in August of the award year. The awarded funds may be used at the discretion of the Pew scholar, for personnel, equipment, supplies, or travel directly related to the scholar’s research and as to best advance his or her research and career.

The amount of the award that may be used for the principal investigator’s salary is limited to $12,500 per year (including benefits) or $50,000 over the duration of the grant. There are no limits on student or postdoctoral salaries.
Not more than 8 percent ($24,000) of the total award value may be allocated for facilities and administration (F&A) charges or indirect costs (IDCs).
Should the funds not be immediately required, they may be accumulated and carried over through the grant period and, with written approval of the program office, the grant may receive a no-cost extension for one additional year (without additional funds).
Subawards are allowed.

PAR-23-077: Collaborative Program Grant for Multidisciplinary Teams (RM1 – Clinical Trial Optional)

Slots: 2

Deadlines

Internal Deadline: Contact RII.

LOI: 30 days prior.

External Deadline: May 26, 2023

Recurring Deadlines: January 26, 2024; May 29, 2024; January 28, 2025; May 28, 2025; January 27, 2026

Award Information

Award Type: Grant

Estimated Number of Awards: 4-6

Anticipated Award Amount: While applications may request research program budgets of up to $1.5 million direct costs per year, it is anticipated that most awards will be between $700,000-$900,000 direct costs. Annual inflationary increases are not allowed. The requested budget should be consistent with the number of PDs/PIs and the complexity and needs of the proposed program. An additional $250,000 direct costs per year may be requested for optional developmental funds to support the addition of ESIs to the program in years 2-5.

Who May Serve as PI:

The application is required to be submitted as a multiple PD/PI application, with three to six PDs/PIs. All PDs/PIs must have an appointment at a domestic institution. Scientists employed solely by foreign institutions may not serve as one of the PDs/PIs of the multiple PD/PI team, although they may be included in the application as collaborators/co-investigators, consultants, or other significant contributors. See the multiple PD/PI Policy and submission details in the Senior/Key Person Profile (Expanded) Component of the SF424 (R&R) Application Guide, and the Grant Policy Statement on Multiple Principal Investigators. Minimum allowed efforts by the PDs/PIs are described in the R&R Budget instructions in Part 2. Section IV.2.

Any eligible scientists with the interest and ability to develop a team science program to address an important research question are welcome to apply.

NIGMS encourages the participation of early career investigators as part of the multiple PD/PI team as appropriate.
- Note that ESIs and new investigators who participate as a PD/PI will lose their ESI or new investigator status for future NIH applications.
- ESIs supported by developmental funds in future years are not designated as PDs/PIs and will not lose ESI status.
PDs/PIs who have an active NIGMS R35 award can participate as a RM1 PD/PI. Their RM1 effort will be part of the 51% research effort on their current R35 award but may not receive additional funds .
Applicants with substantial unrestricted research support may receive funding from this award as their one NIGMS grant award, or may participate in an unfunded advisory or consulting role without loss of their ability to receive one funded NIGMS grant, consistent with NIGMS funding policies.

Link to Award: https://grants.nih.gov/grants/guide/pa-files/PAR-23-077.html

Process for Limited Submissions

RII-Limited-Submission-Application-Template.

Materials to submit include:

(1) Two-Page Proposal Summary (0.5” margins; single-spaced; font type: Arial, Helvetica, or Georgia typeface; font size: 11 pt). Page limit includes references and illustrations. Pages that exceed the 2-page limit will be excluded from review. You must use the template linked above.
(2) CV – (5 pages maximum)

Purpose

Complex and challenging research questions benefit from the integrated efforts of teams/labs employing complementary approaches with multiple areas of expertise. Team-based efforts can converge on high-impact discoveries, such as creating new disciplines, resolving longstanding or intractable problems, or defining new areas that challenge existing paradigms.

This funding opportunity announcement (FOA) encourages Collaborative Program Grant applications from institutions/organizations that propose projects addressing complex and challenging biomedical problems within the mission of NIGMS. Multidisciplinary research teams must have a highly integrated approach for each of their project goals. The Collaborative Program Grant is designed to support research in which funding a team of interdependent investigators to achieve a unified scientific goal offers significant advantages over supporting individual research project grants.

Features of successful applications include:

Each PD/PI is committed to team science and willing to devote a major part of their research effort to the team project.
Achieving the goal(s) requires a team approach.
Each biological question posed requires a cohesive team with an integrated approach.
A team management structure is developed for achieving program goals.

NIGMS recognizes that diverse teams working together and capitalizing on innovative ideas and distinct perspectives outperform homogeneous teams. There are many benefits that flow from a diverse scientific workforce, including fostering scientific innovation, enhancing global competitiveness, contributing to robust learning environments, improving the quality of the research, advancing the likelihood that underserved populations participate in, and benefit from, research and enhancing public trust. To support the best science, NIGMS encourages inclusivity in research. Examples of structures that promote diverse perspectives include but are not limited to:

Engagement from different types of institutions and organizations (e.g., research-intensive, undergraduate-focused, minority-serving, community-based).
Individual applications and partnerships that enhance geographic and regional engagement.
Investigators and teams composed of researchers at different career stages.
Participation of individuals from diverse backgrounds, including groups traditionally underrepresented in the biomedical, behavioral, and clinical research workforce (see NOT-OD-20-031), such as underrepresented racial and ethnic groups, those with disabilities, those from disadvantaged backgrounds, and women.
Project-based opportunities to benefit early- and mid-career investigators.

This FOA requires a Plan for Enhancing Diverse Perspectives (PEDP) as part of the application (see Section IV.2 SF424(R&R) Other Project Information. Other Attachments). For further information on the Plan for Enhancing Diverse Perspectives (PEDP), please see https://braininitiative.nih.gov/about/pedp-key-elements-and-examples.

Applications may address any area of science within the NIGMS mission. NIGMS supports generalizable, foundational basic research that increases understanding of biological processes at a range of levels, from molecules and cells, to tissues, whole organisms, and populations. NIGMS also supports research in a limited number of clinical areas that affect multiple organ systems. Truly new interdisciplinary ideas for approaching significant biological problems are encouraged. Applications that bridge the research interests of more than one area of science supported by NIGMS are also encouraged but must remain within the NIGMS mission.

Research with the overall goal of gaining knowledge about a specific organ or organ system, or the pathophysiology, treatment, or cure of a specific disease or condition will, in most cases, be more appropriate for another Institute or Center. Consultation with NIGMS staff (see below) prior to preparing an application is strongly encouraged.

Projects outside the NIGMS mission will be rejected without review.

Applicants for smaller projects with one or two PD/PIs should consider submitting a multi-PD/PI application to the “NIH Research Project Grant (Parent R01)” FOA (see the Parent Announcement website for the current issuance of that FOA), or if they are current NIGMS R35 MIRA awardees, they could consider collaborating as part of the 51% research effort on their current R35 award (note they will not receive additional funds from the RM1).

Applications that are mainly focused on the creation, expansion, and/or maintenance of community resources, or on infrastructure development, are not appropriate for this FOA. Although Collaborative Program Grants may include some technology development, applications with a central focus on the creation of new technologies would not be considered for funding as a Collaborative Program Grant and are more appropriate for the other NIGMS mechanism for funding technology research and resources.

Applications that employ specific cells or tissues to address a fundamental biomedical question are appropriate. However, applications that focus solely on a specific organ or disease state and that are within the mission areas of other NIH Institutes and Centers would not be appropriate for this FOA.

Research involving human subjects is permitted in the Collaborative Program Grant. Clinical research must be completely within the context of the NIGMS clinical areas (anesthesiology, clinical pharmacology, sepsis, injury, and critical illness). Mechanistic clinical trials are permitted when the mechanistic study is an essential part of the research program. Clinical trials that are designed to test safety and efficacy of interventions (Phase I, Phase II, Phase III) for the purpose of future clinical treatment and/or regulatory approval are not permitted. Potential applicants are encouraged to confer with the NIGMS Scientific/Research staff (in Section VII. Agency Contacts of this FOA) before submitting an application that includes clinical research. NIGMS does not intend to fund applications that contain clinical research within the missions of other Institutes and Centers at NIH or other federal agencies.

Program Organization

Applications submitted to this FOA are expected to propose a single, well-integrated research plan of sufficient scope, complexity, and impact to justify the investment of significant resources. Applicants are expected to describe a cohesive program with a single set of specific aims sufficient to accomplish program objectives that can be achieved within a maximum of ten years (one five-year program with one five-year competitive renewal). Program objectives that are not likely to be achieved within ten years are not appropriate for this FOA.

Applications that propose extrapolations of a single line of research or propose parallel but independent advancement of different areas are not appropriate for this FOA.

Applicant teams should be nimble to incorporate new knowledge and techniques to achieve program objectives and tackle unanticipated challenges. The application may include early-stage investigtor (ESI)-led development projects in future years to investigate new, but related, lines of research.

Team Management and Optional Activities

An RM1 must be a multiple PI application. Therefore, applicants must include a MPI leadership plan as required by the NIH. In addition, applications are expected to develop a comprehensive team management plan that addresses the following:

Appropriate organizational structure and team composition
Shared leadership, contributions, and distributed responsibility for decision making
Resource allocation
Plans for professional development
Conflict resolution

Applicants may wish to address how they will develop trust and a shared vision, as well as how shared responsibilities, interpersonal interactions, and professional credit will be managed. Additionally, applicants may consider a scientific project manager or program coordinator as part of the management plan.

Collaborative Program Grant applications may propose the use of optional future year developmental funds to support ESIs at domestic institutions whose availability was unknown and/or who can bring new ideas and expertise to the program that was not initially conceived to be relevant at the time of application. Developmental funds are in addition to the base grant budget and will be made available after the first year of the award, subject to NIGMS staff approval and availability of funds. See Section VI. Award Administration Information. Prior Approval for Use of Developmental Funds.

The proposed new work that ESIs will pursue must be well aligned with the aims of the original grant.

If the application requests developmental funds for studies directed by ESIs, plans must be included for selecting the ESIs and for leveraging existing resources for appropriate mentoring, including the effective conduct of multidisciplinary team science, as described in Part 2. Section IV.2 of this FOA.

ESIs supported by developmental funds will be able to seek and receive independent funding. A review criterion and funding consideration for any subsequent Renewal application will be evaluation of the outcomes of the ESI mentoring and support, including whether ESIs successfully obtained independent funding. Note that a plan for the use of developmental funds to support ESIs is an optional activity.

Prior Consultation with IC staff

NIGMS intends to fund a limited number of applications. Therefore, consultation with relevant staff at least 10 weeks prior to the application due date is strongly encouraged. Once applicants have identified overall program objectives and PD/PI participants, NIGMS staff may be able to advise applicants whether the proposed research strategy meets the goals and mission of the Institute, whether it addresses one or more high priority research areas, and whether it is appropriate for a Collaborative team program. A collaborative program that is closely related to the goal of a PD/PI’s existing NIGMS-funded research might require that funding be relinquished to avoid scientific overlap. Institute staff will not evaluate the technical and scientific merit of the proposed program in advance; technical and scientific merit will be determined during peer review using the review criteria indicated in this FOA. During the consultation phase, if the proposed research strategy does not meet NIGMS’ programmatic needs, is not appropriate as a Collaborative Program Grant, or is outside the NIGMS mission, applicants will be encouraged to consider other funding opportunities.

Visit our Institutionally Limited Submission webpage for more updates and other announcements.

Department of Energy (DOE) DE-FOA-0002950 EXPRESS: 2023 Exploratory Research for Extreme-Scale Science

Slots: Two slots taken; two slots still available. No more than one pre-application or application for each PI at the applicant institution.

Deadlines

Internal Deadline: Contact RII.

LOI: March 8, 2023

External Deadline: April 19, 2023

Award Information

Award Type: Grant

Estimated Number of Awards: The exact number of awards will depend on the number of meritorious applications and the availability of appropriated funds.

Anticipated Award Amount: $200,000 per year

Who May Serve as PI: All types of applicants are eligible to apply, except nonprofit organizations described in section 501(c)(4) of the Internal Revenue Code of 1986 that engaged in lobbying activities after December 31, 1995.

Link to Award: https://science.osti.gov/-/media/grants/pdf/foas/2023/SC_FOA_0002950.pdf

Process for Limited Submissions

RII-Limited-Submission-Application-Template.

Materials to submit include:

(1) Two-Page Proposal Summary (0.5” margins; single-spaced; font type: Arial, Helvetica, or Georgia typeface; font size: 11 pt). Page limit includes references and illustrations. Pages that exceed the 2-page limit will be excluded from review. You must use the template linked above.
(2) CV – (5 pages maximum)

Purpose

The DOE SC program in Advanced Scientific Computing Research (ASCR) hereby announces its interest in basic research to explore potentially high-impact approaches in scientific computing and extreme-scale science.

Extreme-scale science recognizes that disruptive technology changes are occurring across science applications, algorithms, computer architectures and ecosystems. Recent reports point to emerging trends and advances in high-end computing, massive datasets, scientific machine learning, artificial intelligence (AI) on increasingly heterogeneous architectures, including neuromorphic and quantum systems. Significant innovation will be required in the development of effective paradigms and approaches for realizing the full potential of scientific computing from emerging technologies. Proposed research should not focus strictly on a specific science use case, but rather on creating the body of knowledge and understanding that will inform future advances in extreme-scale science. Consequently, the funding from this FOA is not intended to incrementally extend current research in the area of the proposed project. It is expected that the proposed projects will significantly benefit from the exploration of innovative ideas or from the development of unconventional approaches. DOE is committed to promoting the diversity of investigators and institutions it supports, as indicated by the ongoing use of program policy factors (see Section V) in making selections of awards. To strengthen this commitment, DOE encourages applications that are led by, or include partners from Established Program to Stimulate Competitive Research (EPSCoR)1 states, that are underrepresented in the ASCR portfolio and applications led by individuals from groups historically underrepresented in STEM.

Exploratory Research for Extreme-Scale Science (EXPRESS) opportunities exist for the following research topics:

A) Modeling Future Supercomputing Systems

B) Programming Techniques for Computational Physical Systems

C) Quantum Algorithms across Models

Applications submitted in response to this FOA must substantially address one of the three research topics. Additional details about each topic are provided below.

Visit our Institutionally Limited Submission webpage for more updates and other announcements.

(CLOSED) Alcon Research Institute (ARI) Young Investigator Grants

Slots: Closed.

Deadlines

Internal Deadline: Contact RII.

LOI: N/A

External Deadline: February 15, 2023

Award Information

Award Type: Grant

Anticipated Award Amount: The maximum grant amount is $75,000. The grant will be applied to support the research program of the grant recipient at their institution. A maximum of no more than 10% can be taken from the grant by the institution for Indirect Costs.

Who May Serve as PI: Applicants must be devoting at least 50% of their time toward research.

Link to Award: https://www.alcon.com/alcon-research-institute#grants

Process for Limited Submissions

PIs must submit their application as a Limited Submission through the Research Initiatives and Infrastructure (RII) Application Portal: https://rii.usc.edu/oor-portal/.

Materials to submit include:

(1) Single Page Proposal Summary (0.5” margins; single-spaced; font type: Arial, Helvetica, or Georgia typeface; font size: 11 pt). Page limit includes references and illustrations. Pages that exceed the 1-page limit will be excluded from review.
(2) CV – (5 pages maximum)

Note: The portal requires information about the PIs and Co-PIs in addition to department and contact information, including the 10-digit USC ID#, Gender, and Ethnicity. Please have this material prepared before beginning this application.

Purpose

Alcon Research Institute funds a “virtual institute” that seeks outstanding contributors to ophthalmic research throughout the world and honors them both in a symposium that elite members of the eye research community attend, as well as monetarily through research grants. The Young Investigator Award is intended to encourage, and promote the early independent career development of clinicians and scientists in vision research and ophthalmology.

Visit our Institutionally Limited Submission webpage for more updates and other announcements.

FFAR (Foundation for Food & Agriculture Research) New Innovator in Food & Agriculture Research Award

Slots: 1.

Deadlines

Internal Deadline: Contact RII.

Nominations Due: February 22, 2023, 5pm ET/2pm PT

External Deadline: May 3, 2023, 5pm ET

Award Information

Award Type: Grant

Anticipated Award Amount: Each applicant can receive from FFAR up to $150,000 per year for a maximum of three years totaling $450,000 investment. Indirect costs are limited to 10% of the total award, including subcontracts, if applicable. Unrecovered indirect cost is not permitted. Construction and renovation costs are not allowed. Salaries of principal investigators are allowed for time not covered by institutional or other grant funds and effort should be commensurate with the research proposed.

Who May Serve as PI: We give preference to individuals who are within eight years of receiving a Ph.D. or equivalent degree. Eligible candidates must also conduct research that aligns with our Challenge Areas.

Link to Award: https://foundationfar.org/grants-funding/opportunities/new-innovators-request-for-applications/

Process for Limited Submissions

PIs must submit their application as a Limited Submission through the Research Initiatives and Infrastructure (RII) Application Portal: https://rii.usc.edu/oor-portal/.

Materials to submit include:

(1) Single Page Proposal Summary (0.5” margins; single-spaced; font type: Arial, Helvetica, or Georgia typeface; font size: 11 pt). Page limit includes references and illustrations. Pages that exceed the 1-page limit will be excluded from review.
(2) CV – (5 pages maximum)

Purpose

The New Innovator in Food & Agriculture Research Award provides early-career scientists the investment needed to propel them into successful research careers.

Young faculty in the sciences often struggle to secure grant funding. We established the New Innovator Awards to launch the careers of promising scientists whose research addresses significant food and agriculture challenges. These awards allow the grantees to focus exclusively on research without the pressure of securing additional funding.

We grant New Innovator Awards to outstanding early career investigators who have been in the tenure-track position no longer than three years. The Award goes to individuals with the creative ideas, skills, knowledge and resources necessary to carry out the proposed research program.

Individuals with significant research experience prior to obtaining their faculty position are not eligible for this award.

Visit our Institutionally Limited Submission webpage for more updates and other announcements.

« Previous Page